A Randomized, Multiple-Dose,Double-Blind,Crossover Trial to Assess the Systemic Exposure of Fluticasone Propionate (FP)/Formoterol Fumarate (FF) Fixed-Dose Combination in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2013
At a glance
- Drugs Fluticasone propionate; Formoterol; Formoterol/fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Dey Laboratories
- 26 Feb 2013 Last checked against ClinicalTrials.gov.
- 25 Sep 2009 Actual patient number (97) added as reported by ClinicalTrials.gov.
- 25 Sep 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.